Our frames for battery cells ensure performance and help with thermal management. During development, we rely on highly specialized computer simulations.   

With our battery cell frames, we provide a home for one of the most important components of electromobility. This is not just about a mere holder for the vehicle battery.

HELLA, the automotive supplier operating under the umbrella brand FORVIA, today completed the exit from the joint venture HBPO Beteiligungsgesellschaft mbH ("HBPO"). Following the approval of the responsible regulatory authorities, the 33.33 percent share in the joint venture has been successfully transferred to the previous co-shareholder Plastic Omnium. The purchase price amounts to € 290 million, including a dividend of approximately € 8 million. HELLA and Plastic Omnium had agreed on a corresponding share purchase and assignment agreement in July this year.

SymBio Pharmaceuticals Limited (Headquarters: Tokyo, "SymBio" or the “Company”) today announced that the Company, together with Eagle Pharmaceuticals, Inc. (Headquarters: New Jersey, U.S.A., “Eagle”), the Company's licensor, jointly filed a complaint in the Tokyo District Court against Pfizer Japan Inc. (Headquarters: Tokyo, “Pfizer”) seeking remedies for the infringement of Eagle’s patents for TREAKISYM® injection solution 100mg/4mL (generic name: bendamustine hydrochloride hydrate, hereinafter “TREAKISYM®”).

the Supervisory Board of Continental AG resolved to create the new Executive Board function “Integrity and Law,” which will be headed by Olaf Schick. He has been appointed to Continental’s Executive Board for a three-year period effective July 1, 2023, expanding the board to six members.